|
| Exchange Disseminated Time | Concord Drugs Ltd has informed BSE that the Company has, in compliance with the requirements of the Regulation 8 & Regulation 9 of the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with SEBI circular dated May 11, 2015 the Board of Directors through circular resolution dated May 12, 2015 formulated and adopted the following:
1. Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information and also being published on the official website of the Company.
2. Code of Conduct to regulate, monitor and report trading by its employees and other connected person. |
|
|